Distribution of androstenedione and its effects on total free fatty acids in pregnant rats

Abstract

Androstenedione, an anabolic steroid used to enhance athletic performance, was administered in corn oil by gastric intubation once daily in the morning to nonpregnant female rats at a dose of 5 or 60mg/kg/day, beginning two weeks before mating and continuing through gestation day (GD) 19. On GD 20, the distribution of androstenedione and other steroid metabolites was investigated in the maternal plasma and target organs, including brain and liver. The concentration of estradiol in plasma approached a statistically significant increase after treatment as compared with the controls, whereas the levels of androstenedione, testosterone and progesterone were not significantly different from the controls. In the liver, the concentrations of androstenedione and estradiol only were increased in a dose-related manner. None of these steroids was detectable in the brain. Androstenedione treatment also produced changes in the level of selected free fatty acids (FFAs) in the maternal blood, brain, liver and fetal brain. The concentrations of palmitic acid (16:0) and stearic acid (18:0) in the plasma were not significantly different between the controls and treated rats. However, oleic acid (18:1), linoleic acid (18:2) and docosahexaenoic acid (DHA, 22:6) were 17.94 ± 2.06 μg/ml, 24.23 ± 2.42 μg/ml and 4.08 ± 0.53 μg/ml, respectively, in the controls, and none of these fatty acids was detectable in the treated plasma. On the other hand, palmitic, stearic, oleic, linoleic and DHA were present in both control and treated livers. Among the FFAs in liver, linoleic and DHA were increased 87% and 169%, respectively, over controls. Palmitic, stearic and oleic acids were not significantly affected by the 60 mg/kg treatment. These were present in both control maternal and fetal brains, whereas linoleic acid was found only in fetal brain control. DHA was present only in the control maternal brain (0.02 ± 0.02 μg/mg protein) and fetal brain (0.24 ± 0.15 μg/mg protein). The results indicated that androstenedione exhibits significantly different effects on the FFA composition among target organs during pregnancy.

Keywords

androstenedione free fatty acids Oxidative stress brain liver pregnant rats

Get full access to this article

View all access options for this article.

References

Abbott, D.A. , Batty, K.A. , Dubey, A.K. et al. 1985: The passage of 5 alpha-dihydrotestosterone from serum into cerebrospinal fluid and LH negative feedback in castrated rhesus monkeys. The Journal of Endocrinology 104, 325—30.

Binienda, Z. and Kim, C.S. 1997: Increase in levels of total free fatty acids in rat brain regions following 3-nitropropionic acid administration, Neuroscience Letter 230, 199—201.

Brown, G.A. , Dewey, J.C. , Brunkhorst, J.A. et al. 2004: Changes in serum testosterone and estradiol concentrations following acute androstenedione ingestion in young women. Hormone and Metabolic Research 36, 62—66.

Connor, W.E. and Neuringer, M. 1988: The effects of n-3 fatty acid deficiency and repletion upon the fatty acid composition and function of the brain and retina. Progress in Clinical and Biological Research 282, 275—294.

Duran, M. , Mitchell, G. , de Klerk, J.B. et al. 1985: Octanoic acidemia and octanoylcarnitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acids. The Journal of Pediatrics 107, 397—404.

Duttaroy, A.K. 2004: Fetal growth and development: roles of fatty acid transport proteins and nuclear transcription factors in human placenta. Indian Journal of Experimental Biology 42, 747—757.

Flynn, T.J. , Sapienza, P.P. , Wiesenfeld, P.W. et al. 2005: Effects of oral androstenedione on steroid metabolism in liver of pregnant and non-pregnant female rats. Food Chemical Toxicology, 43, 537—542.

Giugliano, D. , Paolisso, G. and Ceriello, A. 1996: Oxidative stress and diabetic vascular complications . Diabetes Care 19, 257—267.

Kadenbach, B. , Arnold, S. , Lee, I. et al. 2004: The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases. Biochimica et Biophysica Acta 1655, 400—408.

10.

Kim, C.S. , Roe, C.R. and Ambrose, W.W. 1990: L-Carnitine prevents mitochondrial damage induced by octanoic acid in the rat choroid plexus. Brain Research 536, 335—338.

11.

Kubota, T. , Fujisaki, K. , Itoh, Y. et al. 2004: Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors. Biochemical Pharmacology 67, 2175—2186.

12.

Larrey, D. and Pageaux, G.P. 2005: Drug-induced acute liver failure. European Journal of Gastroenterology & Hepatology 17, 141—143.

13.

Lu, S.C. 1999: Regulation of hepatic glutathione synthesis: current concepts and controversies The FASEB Journal 13, 1169—1183.

14.

Lystad, E. , Hostmark A.T. and Jebens, E. 2001: Apoptotic effects of dichloro stearic and dichloro myristic acid in human hepatoma cells (HepG2). Pharmacology & Toxicology 89, 85—91.

15.

Markesbery, W.R. 1997: Oxidative stress hypothesis in Alzheimer's disease . Free Radical Biology & Medicine 23, 134—147.

16.

McCall, A.L. , Han, S.J. , Millington, W.R. et al. 1981: Non-saturable transport of [3H]oestradiol across the blood-brain barrier in female rats is reduced by neonatal serum . Journal of Reproduction & Fertility 61, 103—108.

17.

NTP , 2004: Testing status: androstenedione . Available at: http://ntp.niehs,nih.gov/index.cfm/objectid=7182FF77-BDB7-CEBA-FD9E24BEIA5D9437 .

18.

Ockner, R.K. 2001: Apoptosis and liver diseases: recent concepts of mechanism and significance. Journal of Gastroenterology Hepatology 16, 248—60.

19.

Ozawa, T. 1997: Genetic and functional changes in mitochondria associated with aging, Physiological Reviews 77, 425—464.

20.

Piantadosi, C.A. and Zhang, J. 1996: Mitochondrial generation of reactive oxygen species after brain ischemia in the rats, Stroke 27, 327—331.

21.

Przybyla-Zawislak, B.D. , Kim, C.S. , Ali S.F. et al. 2005; The differential JUNB responses to inhibition of succinate dehydrogenase in rat hippocampus and liver. Neuroscience Letters 381, 354—357.

22.

Purdon, M.P. and Lehman-McKeeman, L.D. 1997: Improved high-performance liquid chromatographic procedure for the separation and quantification of hydroxytestosterone metabolites. Journal of Pharmacological and Toxicological methods 37, 67—73.

23.

Roe, C.R. and Coates, P.M. 1989: Acyl-CoA dehydrogenase deficiencies. In: Scriver, CR , Beaudet, AL , Sly, WS and Valle, D. , editors. The Metabolic Basis of Inherited Disease, Vol. 6. McGray-Hill, New York, NY 1989; 889—914.

24.

Sahu, S.C. , Sapienza, P.P. , Sprando, R.L. et al. 2005: Hepatotoxicity of androstenedione in pregnant rats. Food and Chemical Toxicology, 43, 341—344.

25.

Smith, P.K. , Krohn, R.I. , Hermanson, G.T. et al. 1985: Measurement of protein using bicinchoninic acid. Analytical Biochemistry 150, 76—85.

26.

Sprando, R.L. , Collins, T.F.X. , Black, T.N. et al. 2004: Effects of androstenedione on in utero development in rats. Food and Chemical Toxicology 42, 917—924.

27.

Sprando, R.L. , Collins, T.F.X. , Black, T.N. et al. 2005: Maternal exposure to androstenedione does not induce developmental toxicity in the rat. Food and Chemical Toxicology 43, 505—513.

28.

Starkebaum, G. and Harlan, J.M. 1986: Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homo-cysteine. The Journal of Clinical Investigation 77, 1370—1376.

29.

Symczak, J. , Milewicz, A. , Thijssen, J.H. et al. 1998: Concentration of sex steroids in adipose tissue after menopause. Steroids 63, 319—321.

30.

Ulloth, J.E. , Casiano, C.A. and De Leon, M. 2003: Palmitic and stearic fatty acids induce caspase-dependent and -independent cell death in nerve growth factor differentiated PC12 cells . Journal of Neurochemistry 84, 655—68.

31.

Uhr, M. , Holsboer, F. and Muller, M.B. 2002: Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. Journal of Neuroendocrinology 14, 753—759.

32.

Wallace, D.C. 1999: Mitochondrial diseases in man and mouse. Science 283, 1482—1488.

33.

Wiesenfeld, P.W. , Sapienza, P.P. , Flynn, T.J. et al. 2006: Effects of oral androstenedione on phospholipid fatty acids, ATP, caspase-3, prostaglandin E2 and C-reactive protein in serum and livers of pregnant and non-pregnant female rats. Food Chemical Toxicology 44, 579—587.

34.

Wiseman, H. and Halliwell, B. 1996: Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochemical Journal 313, 17—29.

35.

Wolf, C.J. , Hotchkiss, A. , Ostby, J.S. et al. 2002: Effects of prenatal testosterone propionate on the sexual development of male and female rats: a dose-response study. Toxicological Sciences 65, 71—86.

36.

Yeoh, C. , Schreck, C.B. , Fitzpatrick, M.S. et al. 1996: In vivo steroid metabolism in embryonic and newly hatched steel-head trout (Oncorhynchus mykiss). General and Comparative Endocrinology 102, 197—209.

37.

You, L. 2004: Steroid hormone biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymes. Chemico-Biological Interactions 147, 233—246.

38.

Zhu, Y. , Schwarz, S. , Ahlemeyer, B. et al. 2005: Oleic acid causes apoptosis and dephosphorylates Bad. Neurochemistry International 46, 127—35.